Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Debt | Alive

Total Raised


Last Raised

$2.92M | 9 yrs ago

About Cambridge Endoscopic Devices

Cambridge Endoscopic Devices (CED) has developed a line of surgical instruments that aim to address the need for enhanced dexterity and manipulation in laparoscopic and endoscopic surgery. Per the company, these instruments overcome surgical barriers encountered with traditional endoscopic and laparoscopic instruments, allowing for the potential of new surgical procedures and better, more cost effective clinical outcomes.

Cambridge Endoscopic Devices Headquarters Location

119 Herbert Street

Framingham, Massachusetts, 01702,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Cambridge Endoscopic Devices Patents

Cambridge Endoscopic Devices has filed 16 patents.

The 3 most popular patent topics include:

  • Graphical control elements
  • Medical equipment
  • Surgery
patents chart

Application Date

Grant Date


Related Topics




Surgical instruments, Graphical control elements, Medical equipment, Surgical removal procedures, Surgery


Application Date


Grant Date



Related Topics

Surgical instruments, Graphical control elements, Medical equipment, Surgical removal procedures, Surgery



Latest Cambridge Endoscopic Devices News

Cambridge Endoscopic Devices Inc Bankruptcy Notice of Sale of Assets

Sep 29, 2015

UPDATE 1-CVC's QuironSalud studying partial sale of property assets The Proposed Sale is made pursuant to an Asset Purchase Agreement (the “APA”) between the Company and WSB, for a purchase price of $3,100,000. Pursuant to Section 363 (f) of the Bankruptcy Code, the Assets will be sold free and clear of liens, claims and encumbrances as set forth in the APA. A more detailed description of the Assets and the terms and conditions of the proposed sale is contained in the APA. Competing offers must comply with the procedures set forth in the Sale Notice. Competing bids for the Assets must be submitted by November 19, 2015 by 5:00pm EST. Any party that is interested in submitting a bid to purchase the Assets or any substantial portion thereof should contact John Schulte, in order to obtain additional information about the Assets and to arrange for execution and delivery to CED of a confidentiality agreement pursuant to which such additional will be provided. To obtain a copy of the Sale Notice or APA please contact CED’s counsel, Michael Goldberg of Casner & Edwards, LLP, (617) 426-5900, . Cambridge Endoscopic Devices, Inc. has developed and marketed a line of disposable, hand held laparoscopic devices that have full 7 degrees of freedom tip articulation. More than 30 issued patents and additional applications cover this technology for laparoscopic applications as well as other markets. A complete due diligence package is available to prospective bidders. View source version on CED

  • Where is Cambridge Endoscopic Devices's headquarters?

    Cambridge Endoscopic Devices's headquarters is located at 119 Herbert Street, Framingham.

  • What is Cambridge Endoscopic Devices's latest funding round?

    Cambridge Endoscopic Devices's latest funding round is Debt.

  • How much did Cambridge Endoscopic Devices raise?

    Cambridge Endoscopic Devices raised a total of $5.92M.

  • Who are the investors of Cambridge Endoscopic Devices?

    Investors of Cambridge Endoscopic Devices include Boston Harbor Angels and Angel Healthcare Investors.

  • Who are Cambridge Endoscopic Devices's competitors?

    Competitors of Cambridge Endoscopic Devices include GENICON, Dune Medical Devices, Entellus Medical, Surgiquest, Xlumena and 14 more.

You May Also Like

Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.


ClearMedical is a distributor of remanufactured brand name surgical devices. ClearMedical aims to drive cost savings by selling high-volume, disposable, FDA approved laparoscopic, arthroscopic, and general surgical devices at reduced prices. The company collects used Single-Use-Devices (SUDs) from hospitals, reprocesses them consistent with FDA approvals, and sells them to hospitals and surgery centers wanting to reduce supply acquisition costs. The company's device list includes harmonic scalpels from Ethicon, trocars from Ethicon, US Surgical (AutoSuture), laparoscopic instruments from Ethicon, US Surgical (AutoSuture), clip appliers from ethicon, US Surgical (AutoSuture), linear cutter and staplers from Ethicon, and bone shavers from Linvatec, Smith & Nephew, and Stryker.

Mst (Medical Smart Tools)

MST - Medical Smart Tools was founded in 2004 with the mission to develop image guided surgery technology solutions. The Company aims to improve laparoscopic and other minimally invasive surgical procedures and medical staff effectiveness, thus increasing hospital efficiencies, reducing surgical costs, and improving patient outcomes. MST is working within NGT, a private technological incubator in Nazareth, Israel. MST presents the market with a smart disposable Robotic Arm camera holder for laparoscopy, based on advanced image technology. The system is comprised of a computer-controlled mechanism for mechanical camera motivation, intuitive interface between the surgeon and the mechanical system. The company's R&D efforts are spearheaded by a core group of engineers with expertise in image processing, dynamics of mechanisms, multi-link systems and biomechanics. The Company is backed by strong and experienced management and professional medical advisors.

TissueLink Medical

TissueLink Medical is a developer and distributor of medical devices that for surgical procedures. The company's technology aims to eliminate the need for multiple technologies with the potential to reduce operating room and patient recovery time by enabling precise coagulation and cutting, with no excess damage to tissue. These devices will be used in general and thoracic surgical procedures.


NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.

Softscope Medical Technologies

Softscope Medical Technologies is developing a medical technology designed to facilitate the performance of endoscopic procedures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.